STATE of the ART ASSESSMENT of ENDOCRINE DISRUPTERS Final Report

Total Page:16

File Type:pdf, Size:1020Kb

STATE of the ART ASSESSMENT of ENDOCRINE DISRUPTERS Final Report STATE OF THE ART ASSESSMENT OF ENDOCRINE DISRUPTERS Final Report Project Contract Number 070307/2009/550687/SER/D3 Authors: Andreas Kortenkamp, Olwenn Martin, Michael Faust, Richard Evans, Rebecca McKinlay, Frances Orton and Erika Rosivatz 23.12.2011 TABLE OF CONTENTS TABLE OF CONTENTS 0 EXECUTIVE SUMMARY ......................................................................................................................... 7 1 INTRODUCTION .................................................................................................................................... 9 1.1 TERMS OF REFERENCE, SCOPE OF THE REPORT ........................................................................... 9 1.2 STRUCTURE OF THE REPORT ....................................................................................................... 11 2 DEFINITION OF ENDOCRINE DISRUPTING CHEMICALS ...................................................................... 13 2.1 THE ENDOCRINE SYSTEM ............................................................................................................ 13 2.2 ADVERSITY ................................................................................................................................... 15 2.2.1 DEFINITION........................................................................................................................... 15 2.2.2 ASSAY REQUIREMENTS ........................................................................................................ 16 2.2.3 ECOTOXICOLOGICAL EFFECTS .............................................................................................. 16 2.3 MODE OF ACTION ....................................................................................................................... 17 2.4 PROOF OF CAUSALITY ................................................................................................................. 17 2.5 DEFINITIONS OF POTENTIAL AND POSSIBLE ENDOCRINE DISRUPTERS ...................................... 19 2.6 ENDOCRINE MODULATION, ENDOCRINE ACTIVITY, ENDOCRINE MODULATORY ACTIVITY ....... 19 3 FRAMEWORKS FOR REGULATORY TESTING AND SCREENING ........................................................... 21 3.1 THE OECD CONCEPTUAL FRAMEWORK ...................................................................................... 21 3.1.1 CONCEPTUAL FRAMEWORK GUIDANCE DOCUMENT .......................................................... 24 3.1.2 DETAILED REVIEW PAPER ON NOVEL TESTS AND ENDPOINTS ............................................ 26 3.1.3 CORRELATIONS BETWEEN TEST OUTCOMES AT LOWER LEVELS WITH THOSE AT HIGHER LEVELS ........................................................................................................................................... 28 3.2 TIERED TESTING STRATEGIES ...................................................................................................... 30 4 SCIENTIFIC RESULTS OF REGULATORY RELEVANCE ........................................................................... 32 4.1 WEIGHT-OF-EVIDENCE APPROACHES ......................................................................................... 32 4.1.1 EPIDEMIOLOGICAL CRITERIA OF CAUSAL INFERENCE ......................................................... 32 4.1.2 QUALITY CRITERIA FOR TOXICOLOGICAL STUDIES ............................................................... 34 4.1.3 ECHA GUIDANCE ON WEIGHT OF EVIDENCE EVALUATION ................................................. 35 4.1.4 EXAMPLES OF WOE APPROACHES FOR ENDOCRINE DISRUPTERS ...................................... 36 4.1.4.1 WHO/IPCS Global assessment of the state-of-the-science of endocrine disrupters .... 36 4.1.4.2 RPS-BKH Endocrine Disrupters database ...................................................................... 37 4.1.5 IMPLICATIONS FOR THE REGULATION OF ENDOCRINE DISRUPTERS .................................. 38 4.2 CONCEPTUAL FRAMEWORKS FOR EVALUATING EVIDENCE OF MODE OF ACTION(S) ............... 39 4.2.1 MECHANISM, MODE OF ACTION AND KEY EVENTS ............................................................. 39 Page 2 of 135 TABLE OF CONTENTS 4.2.2 MODE OF ACTION ANALYSIS METHODOLOGY ..................................................................... 40 4.3 LOW DOSE EFFECTS AND THRESHOLDS ...................................................................................... 42 4.3.1 CATEGORIES OF MODE OF ACTION THAT CAN INFORM LOW DOSE EXTRAPOLATIONS ..... 43 4.3.2 ABSENCE OF THRESHOLDS AT THE HUMAN POPULATION LEVEL AND IMPORTANCE OF PRE-EXISTING EXPOSURES ............................................................................................................ 44 4.4 CRITICAL WINDOWS OF SENSITIVITY AND IRREVERSIBLE EFFECTS ............................................ 44 4.4.1 IMPLICATIONS FOR TESTING AND REGULATION ................................................................. 45 4.5 MIXTURES .................................................................................................................................... 46 4.6 THRESHOLDS OF TOXICOLOGICAL CONCERN ............................................................................. 46 4.7 ENDPOINTS, MODES-OF-ACTION AND ASSAYS ........................................................................... 47 4.7.1 HUMAN HEALTH .................................................................................................................. 48 4.7.1.1 Reproductive health ...................................................................................................... 48 4.7.1.1.1 Male Reproductive Health ..................................................................................... 48 4.7.1.1.2 Female Reproductive Health ................................................................................. 48 4.7.1.2 Hormonal cancers ......................................................................................................... 49 4.7.1.3 Metabolism and development ...................................................................................... 50 4.7.2 WILDLIFE .............................................................................................................................. 50 4.7.2.1 Invertebrates ................................................................................................................. 50 4.7.2.2 Fish ................................................................................................................................ 52 4.7.2.3 Amphibians ................................................................................................................... 53 4.7.2.4 Reptiles.......................................................................................................................... 54 4.7.2.5 Birds .............................................................................................................................. 55 4.7.2.6 Mammals ...................................................................................................................... 55 4.8 CHEMICALS OF CONCERN AND EXPOSURE ................................................................................. 56 4.8.1 POLYCHLORINATED BIPHENYLS (PCBS) ................................................................................ 59 4.8.2 POLYCHLORINATED DIBENZODIOXINS (PCDDS) AND POLYCHLORINATED DIBENZOFURANS (PCDFS) .......................................................................................................................................... 59 4.8.3 POLYBROMINATED BIPHENYLETHERS (PBDES) .................................................................... 60 4.8.4 PERFLUORINATED COMPOUNDS (PFCS) .............................................................................. 61 4.8.5 PESTICIDES ........................................................................................................................... 61 4.8.5.1 Dicarboxamides ............................................................................................................. 61 4.8.5.2 Azole fungicides ............................................................................................................ 62 4.8.5.3 Triazines ........................................................................................................................ 63 4.8.6 HEAVY METALS ..................................................................................................................... 64 Page 3 of 135 TABLE OF CONTENTS 4.8.7 BISPHENOL A ........................................................................................................................ 65 4.8.8 PHTHALATES......................................................................................................................... 65 4.8.9 PARABENS ............................................................................................................................ 66 4.8.10 OTHER CHEMICALS............................................................................................................. 67 5 EUROPEAN REGULATORY FRAMEWORK ............................................................................................ 69 5.1 CLASSIFICATION AND LABELLING ................................................................................................ 69 5.1.1 CARCINOGENS ...................................................................................................................... 69 5.1.1.1 Definition and categorisation ......................................................................................
Recommended publications
  • OECD Conceptual Framework for Testing and Assessment of Endocrine Disrupters As a Basis for Regulation of Substances with Endocrine Disrupting Properties
    OECDOECD ConceptualConceptual FrameworkFramework for forTesting Testing and and Assessment Assessment of Endocrineof EndocrineDisrupters Disruptersas a basis asfor aregulation basis of forsubstances regulation with of substances endocrine disrupting with endocrineproperties disrupting properties Ulla Hass, Majken Dalgaard, Kirsten Jarfelt and Thuri S.A. Kledal Department of Toxicology and Risk Assessment, Danish Institute for Food and Veterinary Research, Denmark TemaNord 2004:555 OECD Conceptual Framework for Testing and Assessment of Endocrine Disrupters as a basis for regulation of substances with endocrine disrupting properties TemaNord 2004:555 © Nordic Council of Ministers, Copenhagen 2004 ISBN 92-893-1073-1 ISSN 0908-6692 Nordic Council of Ministers Nordic Council Store Strandstræde 18 Store Strandstræde 18 DK-1255 Copenhagen K DK-1255 Copenhagen K Phone (+45) 3396 0200 Phone (+45) 3396 0400 Fax (+45) 3396 0202 Fax (+45) 3311 1870 www.norden.org Nordic Environmental Co-operation Environmental co-operation is aimed at contributing to the improvement of the environment and forestall problems in the Nordic countries as well as on the international scene. The co- operation is conducted by the Nordic Committee of Senior Officials for Environmental Affairs. The co-operation endeavours to advance joint aims for Action Plans and joint projects, exchange of information and assistance, e.g. to Eastern Europe, through the Nordic Environmental Finance Corporation (NEFCO). The Nordic Council of Ministers was established in 1971. It submits proposals on co-operation between the governments of the five Nordic countries to the Nordic Council, implements the Council's recommendations and reports on results, while directing the work carried out in the targeted areas. The Prime Ministers of the five Nordic countries assume overall responsibility for the co-operation measures, which are co-ordinated by the ministers for co-operation and the Nordic Co-operation committee.
    [Show full text]
  • Fighting Bisphenol A-Induced Male Infertility: the Power of Antioxidants
    antioxidants Review Fighting Bisphenol A-Induced Male Infertility: The Power of Antioxidants Joana Santiago 1 , Joana V. Silva 1,2,3 , Manuel A. S. Santos 1 and Margarida Fardilha 1,* 1 Department of Medical Sciences, Institute of Biomedicine-iBiMED, University of Aveiro, 3810-193 Aveiro, Portugal; [email protected] (J.S.); [email protected] (J.V.S.); [email protected] (M.A.S.S.) 2 Institute for Innovation and Health Research (I3S), University of Porto, 4200-135 Porto, Portugal 3 Unit for Multidisciplinary Research in Biomedicine, Institute of Biomedical Sciences Abel Salazar, University of Porto, 4050-313 Porto, Portugal * Correspondence: [email protected]; Tel.: +351-234-247-240 Abstract: Bisphenol A (BPA), a well-known endocrine disruptor present in epoxy resins and poly- carbonate plastics, negatively disturbs the male reproductive system affecting male fertility. In vivo studies showed that BPA exposure has deleterious effects on spermatogenesis by disturbing the hypothalamic–pituitary–gonadal axis and inducing oxidative stress in testis. This compound seems to disrupt hormone signalling even at low concentrations, modifying the levels of inhibin B, oestra- diol, and testosterone. The adverse effects on seminal parameters are mainly supported by studies based on urinary BPA concentration, showing a negative association between BPA levels and sperm concentration, motility, and sperm DNA damage. Recent studies explored potential approaches to treat or prevent BPA-induced testicular toxicity and male infertility. Since the effect of BPA on testicular cells and spermatozoa is associated with an increased production of reactive oxygen species, most of the pharmacological approaches are based on the use of natural or synthetic antioxidants.
    [Show full text]
  • Toxicological Profile for Bisphenol A
    TT TOXICOLOGICAL PROFILE FOR BISPHENOL A September 2009 Integrated Risk Assessment Branch Office of Environmental Health Hazard Assessment California Environmental Protection Agency Toxicological Profile for Bisphenol A September 2009 Prepared by Office of Environmental Health Hazard Assessment Prepared for Ocean Protection Council Under an Interagency Agreement, Number 07-055, with the State Coastal Conservancy LIST OF CONTRIBUTORS Authors Jim Carlisle, D.V.M., Ph.D., Senior Toxicologist, Integrated Risk Assessment Branch Dave Chan, D. Env., Staff Toxicologist, Integrated Risk Assessment Branch Mari Golub, Ph.D., Staff Toxicologist, Reproductive and Cancer Hazard Assessment Branch Sarah Henkel, Ph.D., California Sea Grant Fellow, California Ocean Science Trust Page Painter, M.D., Ph.D., Senior Toxicologist, Integrated Risk Assessment Branch K. Lily Wu, Ph.D., Associate Toxicologist, Reproductive and Cancer Hazard Assessment Branch Reviewers David Siegel, Ph.D., Chief, Integrated Risk Assessment Branch i Table of Contents Executive Summary ................................................................................................................................ iv Use and Exposure ............................................................................................................................... iv Environmental Occurrence ................................................................................................................. iv Effects on Aquatic Life ......................................................................................................................
    [Show full text]
  • Ecdysone: Structures and Functions Guy Smagghe Editor
    Ecdysone: Structures and Functions Guy Smagghe Editor Ecdysone: Structures and Functions Editor Guy Smagghe Laboratory of Agrozoology Faculty of Bioscience Engineering Ghent University Belgium ISBN 978-1-4020-9111-7 e-ISBN 978-1-4020-9112-4 Library of Congress Control Number: 2008938015 © 2009 Springer Science + Business Media B.V. No part of this work may be reproduced, stored in a retrieval system, or transmitted in any form or by any means, electronic, mechanical, photocopying, microfilming, recording or otherwise, without written permission from the Publisher, with the exception of any material supplied specifically for the purpose of being entered and executed on a computer system, for exclusive use by the purchaser of the work. Printed on acid-free paper springer.com Preface The 16th International Ecdysone Workshop took place at Ghent University in Belgium, July 10–14, 2006 and drew some 150 attendees, many of these young students and postdoctoral associates. These young scientists had the opportunity to dis- cuss their work with many senior scientists at meals, breaks and during the several social events, and were encouraged to do so. This book resulting from the meeting is more up-to-date than might be expected since manuscripts were not delivered to the editor until 2007. The workshop itself had 54 oral presentations as well as many posters. This book, and the meeting itself, is comprised of 23 contributed chapters falling into five general categories: Fundamental Aspects of Ecdysteroid Research: The Distribution and Diversity of Ecdysteroids in Animals and Plants; Ecdysteroid Genetic Hierarchies in Insect Growth and Reproduction; Role of Cross Talk and Growth Factors in Ecdysteroid Titers and Signaling; Ecdysteroid Function Through Nuclear and Membrane Receptors; Ecdysteroids in Modern Agriculture, Medicine, Doping and Ecotoxicology.
    [Show full text]
  • Nuclear Receptor Ftz-F1 Promotes Follicle Maturation and Ovulation
    RESEARCH ARTICLE Nuclear receptor Ftz-f1 promotes follicle maturation and ovulation partly via bHLH/PAS transcription factor Sim Elizabeth M Knapp1, Wei Li1, Vijender Singh2, Jianjun Sun1,2* 1Department of Physiology & Neurobiology, University of Connecticut, Storrs, United States; 2Institute for Systems Genomics, University of Connecticut, Storrs, United States Abstract The NR5A-family nuclear receptors are highly conserved and function within the somatic follicle cells of the ovary to regulate folliculogenesis and ovulation in mammals; however, their roles in Drosophila ovaries are largely unknown. Here, we discover that Ftz-f1, one of the NR5A nuclear receptors in Drosophila, is transiently induced in follicle cells in late stages of oogenesis via ecdysteroid signaling. Genetic disruption of Ftz-f1 expression prevents follicle cell differentiation into the final maturation stage, which leads to anovulation. In addition, we demonstrate that the bHLH/PAS transcription factor Single-minded (Sim) acts as a direct target of Ftz-f1 to promote follicle cell differentiation/maturation and that Ftz-f1’s role in regulating Sim expression and follicle cell differentiation can be replaced by its mouse homolog steroidogenic factor 1 (mSF-1). Our work provides new insight into the regulation of follicle maturation in Drosophila and the conserved role of NR5A nuclear receptors in regulating folliculogenesis and ovulation. Introduction *For correspondence: [email protected] Female fertility, an essential half of the reproductive equation, requires proper follicle maturation and ovulation. The NR5A family of nuclear receptors are critical for the success of these complex Competing interests: The ovarian processes across species (Jeyasuria et al., 2004; Meinsohn et al., 2019; Mlynarczuk et al., authors declare that no 2013; Sun and Spradling, 2013; Suresh and Medhamurthy, 2012).
    [Show full text]
  • Characterization of the Novel Role of Ninab Orthologs from Bombyx Mori and Tribolium Castaneum T
    Insect Biochemistry and Molecular Biology 109 (2019) 106–115 Contents lists available at ScienceDirect Insect Biochemistry and Molecular Biology journal homepage: www.elsevier.com/locate/ibmb Characterization of the novel role of NinaB orthologs from Bombyx mori and Tribolium castaneum T Chunli Chaia, Xin Xua, Weizhong Sunb, Fang Zhanga, Chuan Yea, Guangshu Dinga, Jiantao Lia, ∗ Guoxuan Zhonga,c, Wei Xiaod, Binbin Liue, Johannes von Lintigf, Cheng Lua, a State Key Laboratory of Silkworm Genome Biology, Key Laboratory of Sericultural Biology and Genetic Breeding, Ministry of Agriculture and Rural Affairs, College of Biotechnology, Southwest University, Chongqing 400715, China b College of Animal Science and Technology, Southwest University, Chongqing 400715, China c Life Sciences Institute and the Innovation Center for Cell Signaling Network, Zhejiang University, Hangzhou 310058, China d College of Plant Protection, Southwest University, Chongqing 400715, China e Sericulture Research Institute, Sichuan Academy of Agricultural Science, Chengdu 610066, China f Department of Pharmacology, Case Western Reserve University, School of Medicine, Cleveland, OH 44106, USA ABSTRACT Carotenoids can be enzymatically converted to apocarotenoids by carotenoid cleavage dioxygenases. Insect genomes encode only one member of this ancestral enzyme family. We cloned and characterized the ninaB genes from the silk worm (Bombyx mori) and the flour beetle (Tribolium castaneum). We expressed BmNinaB and TcNinaB in E. coli and analyzed their biochemical properties. Both enzymes catalyzed a conversion of carotenoids into cis-retinoids. The enzymes catalyzed a combined trans to cis isomerization at the C11, C12 double bond and oxidative cleavage reaction at the C15, C15′ bond of the carotenoid carbon backbone. Analyses of the spatial and temporal expression patterns revealed that ninaB genes were differentially expressed during the beetle and moth life cycles with high expression in reproductive organs.
    [Show full text]
  • Toxicological and Health Aspects of Bisphenol A
    Toxicological and Health Aspects of Bisphenol A Report of Joint FAO/WHO Expert Meeting 2–5 November 2010 and Report of Stakeholder Meeting on Bisphenol A 1 November 2010 Ottawa, Canada Food and Agriculture Organization of the United Nations WHO Library Cataloguing-in-Publication Data Joint FAO/WHO expert meeting to review toxicological and health aspects of bisphenol A: final report, including report of stakeholder meeting on bisphenol A, 1-5 November 2010, Ottawa, Canada. 1.Phenols - toxicity. 2.Food contamination. 3.Food packing. I.World Health Organization. II.Food and Agriculture Organization of the United Nations. ISBN 978 92 14 156427 4 (NLM classification: QV 223) © World Health Organization 2011 All rights reserved. Publications of the World Health Organization are available on the WHO web site (www.who.int) or can be purchased from WHO Press, World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland (tel.: +41 22 791 3264; fax: +41 22 791 4857; e-mail: [email protected]). Requests for permission to reproduce or translate WHO publications – whether for sale or for noncommercial distribution – should be addressed to WHO Press through the WHO web site (http://www.who.int/about/licensing/copyright_form/en/index.html). The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement.
    [Show full text]
  • Molecular Biology of Bhlh PAS Genes Involved in Dipteran Juvenile Hormone Signaling
    Molecular Biology of bHLH PAS Genes Involved in Dipteran Juvenile Hormone Signaling Dissertation Presented in Partial Fulfillment of the Requirements for the Degree Doctor of Philosophy in the Graduate School of The Ohio State University By Aaron A. Baumann. B.S. Graduate Program in Entomology The Ohio State University 2010 Dissertation Committee: Thomas G. Wilson, Advisor David Denlinger H. Lisle Gibbs Amanda Simcox Copyright by Aaron A. Baumann 2010 Abstract Methoprene tolerant (Met), a member of the bHLH-PAS family of transcriptional regulators, has been implicated in juvenile hormone (JH) signaling in Drosophila melanogaster. Met mutants are resistant to the toxic and morphogenetic defects of exogenous JH application. A paralogous gene in D. melanogaster, germ cell expressed (gce), forms JH-sensitive heterodimers with MET, but a function for gce has not been reported. DmMet orthologs from three mosquito species are characterized and, based on sequence analysis and intron position, are shown to have higher sequence identity to Dmgce than to DmMet. An evolutionary scheme for the origin of Met from a gce-like ancestor gene in lower Diptera is proposed. RNAi-driven underexpression of Met in the Yellow Fever mosquito, Aedes aegypti, results in the concomitant reduction of putative JH-inducible genes, suggesting involvement in JH signaling. The viability of D. melanogaster Met mutants is thought to result from functional redundancy conferred by gce. Therefore, genetic manipulation of gce expression was used to probe the function of this gene. Overexpression of gce was shown to alleviate preadult, but not adult Met phenotypes. RNAi-driven underexpression of gce resulted in ii preadult lethality in both Met+ and Met mutant backgrounds.
    [Show full text]
  • Compared Activity of Agonist Molecules Towards Ecdysone
    PESTICIDES / SCIENTIFIC COMMUNICATION DOI: 10.1590/1808-1657000312019 Compared activity of agonist molecules towards ecdysone receptor in insect cell-based screening system Comparação da atividade de moléculas agonistas em relação ao receptor de ecdisona em um sistema de triagem baseado em linhagens celulares de insetos Ciro Pedro Guidotti Pinto1,2* , Letícia Neutzling Rickes2 , Moisés João Zotti2 , Anderson Dionei Grutzmacher2 ABSTRACT: The ecdysone receptor, naturally activated by ste- RESUMO: O receptor de ecdisona, naturalmente ativado por hor- roidal hormones, is a key protein for molting and reproduction mônios esteroidais, é uma proteína-chave nos processos de muda e processes of insects. Artificial activation of such receptor by specific reprodução de insetos. A ativação artificial desse receptor por meio de pesticides induces an anomalous process of ecdysis, causing death pesticidas específicos induz um processo de ecdise anômala, levando o of insects by desiccation and starvation. In this paper, we establi- inseto à morte por dessecação e inanição. Neste trabalho, foi estabele- shed a protocol for screening agonistic molecules towards ecdysone cido um protocolo para a triagem de moléculas agonistas em relação ao receptor of insect cells line S2 (Diptera) and Sf9 (Lepidoptera), receptor de ecdisona nas linhagens celulares responsivas S2 (Diptera) e transfected with the reporter plasmid ere.b.act.luc. Therefore, we Sf9 (Lepidoptera), transfectadas com o plasmídeo repórter ere.b.act.luc. set dose-response curves with the ecdysteroid 20-hydroxyecdysone, Para tanto, curvas de dose-resposta foram estabelecidas com o ecdiste- the phytoecdysteroid ponasterone-A, and tebufenozide, a pesticide roide 20-hidroxiecdisona, o fitoecdisteroide ponasterona-A e tebufeno- belonging to the class of diacylhydrazines.
    [Show full text]
  • Binding Proteins for an Ecdysone Metabolite in the Crustacean Hepatopancreas (Molting Hormone/Steroid/Sucrose Gradient Oentrifugation) THOMAS A
    Proc. Nat. Acad. Sci. USA Vol. 69, No. 4, pp. 812-815, April 1972 Binding Proteins for an Ecdysone Metabolite in the Crustacean Hepatopancreas (molting hormone/steroid/sucrose gradient oentrifugation) THOMAS A. GORELL*, LAWRENCE I. GILBERTt, AND JOHN B. SIDDALL Department of Biological Sciences, Northwestern University, Evanston, Illinois 60201; and Zoecon Research Corporation, Palo Alto, California 94304 Communicated by William S. Johnson, January 20, 1972 ABSTRACT When crustacean hepatopancreas is incu- and incubated at 250 in 3 ml of saline containing [8H]ecdysone bated in the presence of a-[3Hlecdysone of high specific (see figure legends for quantities). After incubation, the tissue activity and is then homogenized and centrifuged, a peak of protein-radioactivity is recovered after gel filtration of was rinsed twice in cold 0.1 M phosphate buffer (pH 7.3) and the 105,000 X g supernatant. Analysis of this peak by su- homogenized in buffer in a ground glass homogenizer at 4°. crose gradient centrifugation revealed the presence of two After centrifugation of the homogenate at 105,000 X g for 1.5 complexes of protein and labeled material (-11.5 S and hr at 40, the supernatant was concentrated with lyphogel and 6.35 S). The same results were obtained in vivo. On stand- for ing at low ionic strength, the lighter component disap- aliquots of the concentrated supernatant were assayed peared, suggesting that the heavier component is an aggre- protein (13) and radioactivity (Packard Tri-carb scintillation gate of the lighter one. Chemical analysis of radioactive ma- spectrometer, model 3375) in ethyl alcohol-toluene [2,5 di- terial in the complex revealed that it is not a- or j3-ecdysone phenyloxazole (PPO), 5 g/l; 1,4-bis-2-(4-methyl-5-phenoxa- nor any previously described metabolite of the ecdysones.
    [Show full text]
  • Benzyl Butyl Phthalate Or BBP)
    Toxicity Review for Benzyl­n­butyl Phthalate (Benzyl Butyl Phthalate or BBP) Introduction Benzyl butyl phthalate (BBP) is a man‐made phthalate ester that is mostly used in vinyl tile (CERHR, 2003). BBP can also be found as a plasticizer in polyvinyl chloride (PVC) for the manufacturing of conveyor belts, carpet, weather stripping and more. It is also found in some vinyl gloves and adhesives. BBP is produced by the sequential reaction of butanol and benzyl chloride with phthalic anhydride (CERHR, 2003). The Monsanto Company is the only US producer of BBP (IPCS, 1999). When BBP is added during the manufacturing of a product, it is not bound to the final product. However, through the use and disposal of the product, BBP can be released into the environment. BBP can be deposited on and taken up by crops for human and livestock consumption, resulting in its entry into the food chain (CERHR, 2003). Concentrations of BBP have been found in ambient and indoor air, drinking water, and soil. However, the concentrations are low and intakes from these routes are considered negligible (IPCS, 1999). Exposure to BBP in the general population is based on food intake. Occupational exposure to BBP is possible through skin contact and inhalation, but data on BBP concentrations in the occupational environment is limited. Unlike some other phthalates, BBP is not approved by the U.S. Food and Drug Administration for use in medicine or medical devices (IPCS, 1999; CERHR, 2003). Based on the National Toxicology Program (NTP) bioassay reports of increased pancreatic lesions in male rats, a tolerable daily intake of 1300 µg/kg body weight per day (µg/kg‐d) has been calculated for BBP by the International Programme on Chemical Safety (IPCS) (IPCS, 1999).
    [Show full text]
  • Toxicological Summary for Bisphenol a (PDF)
    Health Based Guidance for Water Health Risk Assessment Unit, Environmental Health Division 651-201-4899 Adopted as Rule: November 2015 Toxicological Summary for: Bisphenol A CAS: 80-05-7 Synonyms: BPA; 4'-(1-Methylethylidene)bisphenol 4,4'-Bisphenol A; 4,4'- Isopropylidenediphenol; Phenol, 4,4'-(1-methylethylidene)bis- p,p'- isopropylidenebisphenol; 2,2-bis(4-hydroxyphenyl)propane Acute Non-Cancer Health Risk Limit (nHRLAcute) = Not Derived (Insufficient Data) Short-term Non-Cancer Health Risk Limit (nHRLShort-term) = 100 µg/L (Reference Dose, mg/kg/d) x (Relative Source Contribution) x (Conversion Factor) (Short-term intake rate, L/kg-d) = (0.16 mg/kg/d) x (0.2*) x (1000 µg/mg) (0.289 L/kg-d) = 111 rounded to 100 µg/L *MDH utilizes the EPA Exposure Decision Tree (EPA 2000) to select appropriate RSCs. Given the significant potential non- drinking water sources of exposure from multiple sources available for infants, an RSC of 0.2 is selected rather than the default value of 0.5 used for nonvolatile chemicals. Reference Dose/Concentration 0.16 mg/kg-d (rat) Source of toxicity value MDH, 2014 Point of Departure (POD): 2.7 mg/kg-d (NOAEL, Delclos et al. 2014) Human Equivalent Dose (MDH, 2011: 2.7 x 5.8 = 16 mg/kg-d [chemical-specific DAF for neonatal rats] Total uncertainty factor: 100 Uncertainty factor allocation 3 for interspecies differences (for toxicodynamics), 10 for intraspecies variability, and 3 for database uncertainty (additional studies to evaluate latent effects of early life exposure, neurobehavioral, immune system, and metabolic
    [Show full text]